Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)

This study has been completed.
Medicines for Malaria Venture
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: March 18, 2010
Last updated: November 7, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)